← 返回

癌症治疗的新免疫疗法

英文原题:New immunotherapeutic approaches for cancer treatment.

查看英文原题

New immunotherapeutic approaches for cancer treatment.

PubMed 2023/06/19(内容时间) Pathol Res Pract Q1 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤是全球公认的非传染性疾病,其死亡率在心血管疾病之后居首位。数十年来,关于癌症治疗方法的大量研究已催生了化疗、放疗、手术等传统疗法。临床医生和研究人员认为,鉴于高发病率和患病率,迫切需要一种比上述治疗更有效且不良反应更少的替代治疗方案。免疫疗法在几年内已成为一种潜在的替代治疗选择,并成为发展最快的治疗方法之一。不同种类的免疫疗法已获 FDA 批准,可用于治疗各种癌症类型。在本综述中,我们总结了主要的免疫治疗方法,包括检查点抑制剂、CAR-T 细胞疗法和癌症疫苗。此外,本研究还讨论了联合治疗、精准医学、生物标志物发现、克服耐药性和减少不良反应的应用。

展开英文摘要原文

Neoplasms are a worldwide recognized non-contagious disease which has the most mortality rate after cardiovascular diseases. For decades, there has been a vast amount of study on treatment methods of cancer which has led to conventional therapies such as chemotherapy, radiation therapy, surgery and so on. Clinicians and researchers believed that there is an urgent need, considering the high rate of incidence and prevalence, for an alternative treatment option which is more efficacious and has less adverse effects than the above-mentioned treatments.

Immunotherapy has emerged as a potential treatment alternative in a few years and became one of the fastest developing therapeutic approaches. Different kinds of immunotherapies are FDA approved and available for treatment of various cancer types. In this review, we have summarized the major immunotherapy methods including checkpoint inhibitors, CAR T cell therapies and cancer vaccines.

Furthermore, application of combination therapy, precision medicine, biomarker discovery, overcoming resistance and reduction of adverse effects are discussed in this study.

论文信息

作者
Kamrani A、Hosseinzadeh R、Shomali N、Heris JA、Shahabi P、Mohammadinasab R、Sadeghvand S、Ghahremanzadeh K
第一作者单位
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.Iran
通讯作者单位
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: akbarimo@tbzmed.ac.ir.Iran
文献类型
综述
期刊
Pathology, research and practice2023 Aug
原文标识
PubMed 37480597 · DOI 10.1016/j.prp.2023.154632